Loading
Latest filing published 13 Jun 2022 for Vincerx Pharma, Inc., €27k.
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
This profile gathers the share dealings of Laura I. Bushnell in Vincerx Pharma, Inc., where the filings describe the role as board member. The record holds 3 filings, for trades running from 30 June 2021 to 9 June 2022.
Every open-market trade on record is a purchase: 3 purchases worth €69k, and no sale. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Since January 2022: 1 purchase and no sales on the market.
In size, the median ticket on the buying side is €22k. Of 3 purchases, 2 formed part of a group of insiders buying within 30 days of each other. A cluster is several different insiders buying the same stock within a short window, a pattern studied more closely than a single purchase.
On 13 June 2022 came the latest disclosure, an open-market purchase for €27k in Vincerx Pharma, Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
3 of 3 declarations